Lupus erythematosus and nutrition: A review of the literature

Journal of Renal Nutrition

Volumn 10, Issue 4, 2000, Pages 170-183

  Brown, Amy Christine ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MEDICAGO SATIVA; OENOTHERA; PRIMULA; TRIPTERYGIUM; TRIPTERYGIUM WILFORDII;

FISH OIL; HORMONE; MINERAL; VEGETABLE OIL; VITAMIN; ZINC;

ALFALFA; ANGIOSPERM; ANIMAL; CALORIC INTAKE; DIET; DIET THERAPY; DISEASE MODEL; FAT INTAKE; FLAX; HUMAN; IRON INTAKE; MEDLINE; MOUSE; NUTRITION; PATHOPHYSIOLOGY; PHYTOTHERAPY; PROTEIN INTAKE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANGIOSPERMS; ANIMALS; DIET; DIETARY FATS; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; ENERGY INTAKE; FISH OILS; FLAX; HORMONES; HUMANS; IRON, DIETARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDICAGO SATIVA; MEDLINE; MICE; MINERALS; NUTRITION PHYSIOLOGY; PHYTOTHERAPY; PLANT OILS; VITAMINS; ZINC;

EID: 0034293351     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/jren.2000.16323     Document Type: Article

References (142)

1. Talal N: Sex hormones and modulation of immune response in SLE. Arthritis Rheum 8:23-28, 1982
2. Mongey A, Hess EV: Drug and environmental effects of the induction of autoimmunity. J Lab Clin Med 122:652-657, 1993
3. 1 mice. Proc Natl Acad Sci USA 75:1500-1504, 1978
4. Corman LC: The role of diet in animal models of systemic lupus erythematosus: Possible implications for human lupus. Semin Arthritis Rheum 15:61-69, 1985
5. Jolly CA, Fernandes G: Diet modulates Th-1 and Th-2 cytokine production in the peripheral blood of lupus-prone mice. J Clin Immunol 19:172-178, 1999
6. Weindruch R, Walford RL: Dietary restriction in mice beginning at one year of age: Effect on life span and spontaneous cancer incidence. Science 152:1415-1418, 1982
7. Troyer DA, Chandrasekar B, Thinnes T, et al: Effects of energy intake on type 1 plasminogen activator inhibitor levels in glomeruli of lupus-prone B/W mice. Am J Pathol 146:111-120, 1995
8. Troyer DA, Chandrasekar B, Barnes JL, et al: Calorie restriction decreases platelet-derived growth factor (PDGF)-A and thrombin receptor mRNA expression in autoimmune murine lupus nephritis. Clin Exp Immunol 108:58-62, 1997
9. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al: Spontaneousmurine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148:1198-1215, 1978
10. Urao M, Ueda G, Abe M, et al: Food restriction inhibits an autoimmune disease resembling systemic lupus erythematosus in (NZB X NZW)F1 mice. J Nutr 125:2316-2324, 1995
11. Kipen Y, Briganti EM, Strauss BJ, et al: Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus. Rheumatology (Oxford) 38:59-65, 1999
12. 1 mice. Clin Immunol Immunopathol 15:293-300, 1980
13. Chandrasekar B, McGuff HS, Aufdermorte TB, et al: Effects of calorie restriction on transforming growth factor beta-1 and proinflammatory cytokines in murine Sjogren's syndrome. Clin Immunol Immunopathol 70:291-296, 1995
14. 1 mice. Proc Natl Acad Sci USA 91:4402-4406, 1994
15. 2 synthesis in Emory mice. J Nutr 120:112-115, 1990
16. Good RA, Fernandes G, Yunis EJ, et al: Nutritional deficiency, immunologic function, and disease. Am J Pathol 84:599-614, 1976
17. Johnson BC, Gajjar A, Kubo C, et al: Calories versus protein in onset of renal disease in NZB X NZW mice. Proc Natl Acad Sci USA 83:5659-5662, 1986
18. Ihle BU, Becker GJ, Whitworth JA, et al: The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 321:1773-1777, 1989
19. Carr R, Forsyth S, Sadi D: Abnormal responses to ingested substances in murine systemic lupus erythematosus: Apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice. J Rheumatol 14:158-165, 1987 (suppl 13)
20. Mandell EH, Appleton HD: Tryptophan metabolism. R esults of studies in discoid lupus erythematosus. Arch Dermatol 94:358-360, 1966
21. McCormick JP, Fischer JR, Pachlatko JP: Characterization of a cell-lethal product from the photooxidation of tryptophan: Hydrogen peroxide. Science 191:468-469, 1976
22. Dubois EL: Lupus Erythematosus (ed 2). New York, NY, McGraw-Hill, 1966, p 121
23. Shigemasa C, Tanaka T, Mashiba H: Effect of vegetarian diet on systemic lupus erythematosus. Lancet 339:1177, 1992
24. 2 production of immune cells in autoimmune-prone NZB X NZW F1 mice. Br J Nutr 75:711-722, 1996
25. Swanson CA, Levy JA, Morrow WJ: Effect of low dietary lipid on the development of Sjogren's syndrome and haematological abnormalities in (NZB X NZW)F1 mice. Ann Rheum Dis 48:765-770, 1989
26. Alexander NJ, Smythe NL, Jokinen MP: The type of dietary fat affects the severity of autoimmune disease in NZB/ NZW mice. Am J Pathol 127:106-121, 1987
27. Fernandes G, Venkatramna J, Khare A, et al: Modulation of gene expression in autoimmune disease and aging by food restriction and dietary lipids. Proc Soc Exp Biol Med 193:16-22, 1990
28. Levy JA, Ibrahim AB, Shirai T, et al: Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice. Proc Natl Acad Sci USA 79:1974-1978, 1982
29. Yumura W, Hattori S, Morrow WJ, et al: Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB X NZW)F1 mice. J Immunol 135:3864-3868, 1985
30. Erickson KL, Adams DA, Scibienski RJ: Dietary fat acid modulation of murine B-cell responsiveness. J Nutr 116:1830-1840, 1986
31. Jyonouchi H, Sun S, Goodman D, et al: Dietary fatty acid modulates actions of nucleotides on humoral immune responses. Nutrition 11:437-443, 1995
32. Morrow WJ, Homsy J, Swanson CA, et al: Dietary fat influences the expression of autoimmune disease in MRL/lpr/lpr mice. Immunology 59:439-443, 1986
33. Yaqoob P, Calder PC: The effects of dietary lipid manipulation on the production of murine T cell-derived cytokines. Cytokine 7:548-553, 1995
34. 1 mice. J Invest Dermatol 77:381-384, 1981
35. 1 mice fed dehydroisoandrosterone. J Clin Invest 75:2091-2093, 1985
36. Watson J, Godfrey D, Stimson WH, et al: The therapeutic effects of dietary fatty acid supplementation in the autoimmune disease of the MRL-mp-lpr/lpr mouse. Int J Immunopharmacol 10:467-471, 1988
37. Westberg G, Tarkowski A, Svalander C : Effect of eicosapentaenoic acid rich menhaden oil and MaxEPA on the autoimmune disease of Mrl/I mice. Int Arch Allergy Appl Immunol 88:454-461, 1989
38. Thorner A, Walldius G, Nilsson E, et al: Beneficial effects of reduced intake of polyunsaturated fatty acids in the diet for one year in patients with systemic lupus erythematosus [letter]. Ann Rheum Dis 49:134, 1990
39. Beach RS, Gershwin ME, Hurley LS: Nutritional factors and immunity. III. Zinc deprivation versus restricted food intake in MRL/1 mice - The distinction between interacting dietary influences. J Immunol 129:2686-2692, 1982
40. Gershwin ME, Lentz DR, Beach RS, et al: Nutritional factors and autoimmunity. IV. Dietary vitamin A deprivation induces a selective increase in IgM autoantibodies and hypergammaglobulinemiain New Zealand black mice. J Immunol 133:222-226, 1984
41. Leiter LM, Reugh KR, Racis SP, et al: Iron status alters murine systemic lupus erythematosus. J Nutr 125:474-484, 1995
42. Podell RN: Systemic lupus erythematosus. Does diet play a causative role? Postgrad Med 75:251-254, 1984
43. Malonow MR, Bardara EJ, Pirofsky B, et al: Systemic lupuserythematosus-like syndrome in monkeys fed alfalfa sprouts: Role of anonprotein amino acid. Science 216:415-417, 1982
44. Montanaro A, Bardana EJ: Dietary amino acid-induced systemic lupus erythematosus. Rheum Dis Clin North Am 17:323-332, 1991
45. Roberts JL, Hayashi JA: Exacerbation of SLE associated with alfalfa ingestion. N Engl JMed 308:1361, 1983
46. Morimoto I, Shiozawa S, Tanaka Y, et al: L-canavanine acts on suppressor-inducer T cells to regulate antibody synthesis: Lymphocytes of systemic lupus erythematosuspatients are specifically unresponsive to L-canavanine. Clin Immunol Immunopathol 55:97-108, 1990
47. Prete PE: Effects of L-canavanine on immune functioning in normal and autoimmune mice: Disordered B-cell function by a dietary amino acid in the immunoregulation of autoimmune disease. Can J Physiol Pharmacol 63:843-854, 1985
48. Whittam J, Jenson C, Hudson T: Alfalfa, vitamin E, and autoimmune disorders. Am J Clin Nutr 62:1025-1026, 1995
49. Weimann BJ, Hermann D: Inhibition of autoimmune deterioration in MRL/lpr mice by vitamin E. Int J Vitam Nutr Res 69:255-261, 1999
50. Sweet RD: Vitamin E in collagenoses [letter]. Lancet 2:310, 1948
51. Ayers S, Mihan R: Is vitamin E involved in the autoimmune mechanism? Cutis 21:321-325, 1978
52. Burgess JF, Pritchard JE: Tocopherols (vitamin E). Treatment of lupus erythematosus; Preliminary report. Arch Dermatol Syph 57:953-964, 1948
53. Welch AL: Treatment by combined use of massive amounts of pantothenic acid and vitamin E in lupus erythematosus. Arch Dermatol 70:181, 1954
54. Ayres S, Mihan R: Lupus erythematosus and vitamin E: An effective and nontoxic therapy. Cutis 23:49-54, 1979
55. Grubb E, Hagerman G: Our experiences with vitamin E treatment. Acta Derm Venereol 32:256-258, 1952
56. Shinskii GE, Telegina KA, Shephovotsova VV: Experience with vitamin E in the treatment of lupus erythematosus. Dermato Venerol (translation) 36:64, 1962
57. Silver SH, Feigenbaum HL: Chronic discoid lupus erythematosus successfully treated with vitamin E. Arch Dermatol 61:163, 1950
58. Morgan J: A note on the treatment of lupus erythematosus with vitamin E. Br J Dermatol 63:224-225, 1951
59. Sawicky HH: Therapy of lupus erythematosus. Arch Dermatol 61:163, 1950
60. Pascher F, Sawicky HH, Silverberg MG, et al: Tocopherols (vitamin E) for discoid lupus erythematosus and other dermatoses. J Invest Dermatol 17:261-263, 1951
61. Yell JA, Burge S, Wojnarowska F: Vitamin E and discoid lupus erythematosus. Lupus 1:303-305, 1992
62. Juhlin L, Edqvist LE, Ekman LG, et al: Blood glutathioneperoxidase levels in skin diseases: Effect of selenium and vitamin E treatment. Acta Derm Venereol 62:211-214, 1982
63. Gershwin ME, Lentz DR, Beach RS, et al: Nutritional factors and autoimmunity. IV. Dietary vitamin A deprivation induces a selective increase in IgM autoantibodies and hypergammaglobulinemia in New Zealand Black mice. J Immunol 133:222-226, 1984
64. Newbold PCH: Beta-carotene in the treatment of discoid lupus erythematosus. Br J Dermatol 95:100-101, 1976
65. Gergely P, Csaky L, Gonzalez-Cabello P: Immunological effects of retinoids. Tokai J Exp Clin Med 15:235-239, 1990
66. Spallholz JE: Anti-inflammatory, immunologic and carcinostatic attributes of selenium in experimental animals. Adv Exp Med Biol 135:43-62, 1981
67. O'Dell JR, McGivern JP, Kay HD, et al: Improved survival in murine lupus as the result of selenium supplementation. Clin Exp Immunol 73:322-327, 1988
68. James MJ, Cleland LG, Gibson RA, et al: Interaction between fish and vegetable oils in relation to rat leucocyte leudotriene production. J Nutr 121:631-637, 1991
69. Wofsy D: New approaches to treating systemic lupus erythematosus [medical staff conference]. West J Med 147:181-186, 1987
70. Kelley VE, Ferretti A, Izui S, et al: A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL- 1pr mice. J Immunol 134:1914-1919, 1985
71. Watson J, Godfrey D, Stimson WH, et al: The therapeutic effects of dietary fatty acid supplementation in the autoimmune disease of the MR L-mp- 1pr/ 1pr mouse. Int J Immunopharmacol 10:467-471, 1988
72. Robinson DR, Prickett JD, Polisson R, et al: The protective effect of dietary fish oil on murine lupus. Prostaglandins 30:51-75, 1985
73. Chandrasekar B, Troyer DA, Venkatraman JT, et al: Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRN A and protein expression. J Autoimmun 8:381-393, 1995
74. Fernandes G, Bysani C, Venkatraman JT, et al: Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 152:5979-5987, 1994
75. Fernandes G, Chandrasekar B, Luan X, et al: Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids 31:S91-S96, 1996 (suppl)
76. Reifen R, Blank M, Afek A, et al: Dietary polyunsaturated fatty acids decrease anti-DNA and anti-cardiolipin antibodies production in idiotype induced mouse model of systemic lupus erythematosus. Lupus 7:192-197, 1998
77. Hardardottir I, Kinsella JE: Tumor necrosis factor production by murine resident peritoneal macrophages is enhanced by dietary n-3 polyunsaturated fatty acids. Biochem Biophys Acta 1095:187-195, 1991
78. Henderson CD, Black HS, Wolf JE: Influence of omega-3 and omega-6 fatty acid sources on prostaglandin levels in mice. Lipids 24:502-505, 1989
79. Scharschmidt L, Miller M, Holthofer H, et al: A fish oil diet preserves renal function in nephrotoxic serum nephritis. J Lab Clin Med 115:405-414, 1990
80. Kinsella JE, Lokesh B: Dietary lipids, eicosanoids, and the immune system. Crit Care Med 18:S94-S113, 1990 (suppl 2)
81. Haw MP, Bell SJ, Blackburn GL: Potential of parenteral and enterai nutrition in inflammation and immune dysfunction: A new challenge for dietitians. J Am Diet Assoc 91:701-706, 709, 1991
82. Chandrasekar B, Fernandas G: Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by w-3 lipids in murine lupus nephritis. Biochem Biophys Res Commun 200:893-898, 1994
83. Robinson DR, Xu LL, Tateno S, et al: Suppression of autoimmune disease by dietary n-3 fatty acids. J lipid Res 34:1435-1444, 1993
84. Lokesh BR, Hsieh HL, Kinsella JE: Peritoneal macrophages from mice fed dietary (n-3) polyunsaturated fatty acids secrete low levels of prostaglandins. J Nutr 116:2547-2552, 1986
85. Robinson DR, Urakaze M, Huang R, et al: Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. Lipids 31:S23-S31, 1996 (suppl)
86. Blok WL, Katan MB, van der Meer JW: Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 126:1515-1533, 1996
87. Erikson KL, Hubbard NE: Dietary fish oil modulation of macrophage tumoricidal activity. Nutrition 12:S34-S38, 1996 (suppl 1)
88. Westberg G, Tarkdowski A: Effect of maxEPA in patients with SLE. Scand J Rheumatol 19:137-143, 1990
89. Clark WF, Parbtani A, Huff M, et al: Omega-3 fatty acid supplementation in systemic lupus nephritis. Kidney Int 36:653-660, 1989
90. Clark WF, Parbtani A, Naylor CD, et al: Fish oil in lupus nephritis: Clinical findings and methodological implications. Kidney Int 44:75-86, 1993
91. Layne KS, Goh YK, Jumpsen JA, et al: Normal subjects consuming physiological levels of 18:3(n = 3) and 20:5(n = 3) from flaxseed or fish oils have characteristic differences in plasma Lipid and lipoprotein fatty acid levels. J Nutr 126:2130-2140, 1996
92. Ilowite NT, Copperman N, Leicht T, et al: Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus. J Rheumatol 22:1347-1351, 1995
93. Kinsella JE: Dietary polyunsaturated fatty acids affect inflammatory, immune functions. Nutr Rep 8:1, 1990
94. Lotz-Winter H: On the pharmacology of bromelain: An update with special regard to animal studies on dose-dependent effects. Planta Med 56:249-253, 1990
95. Godfrey DG, Stimson WH, Watson J, et al: Effects of dietary supplementation on autoimmunity in the MRL/lpr mouse: A preliminary investigation. Ann Rheum Dis 45:1019-1024, 1986
96. 1 hybrid mice fed an essential fatty acid-deficient diet. JClin Invest 67:476-485, 1981
97. 1 treatment of NZB/NZW mice. I. Prolonged survival of female mice. Arthritis Rheum 20:723-728, 1977
98. Zurier RB, Damjanov I, Sayadoff DM, et al: Prostaglandin E1 treatment of NZB/NZW F hybrid mice. II. Prevention of glomerulonephritis. Arthritis Rheum 20:1449-1456, 1977
99. Leslie C, Meydani S, Cathcart ES, et al: Enhancement of B-cell function in fish oil fed, arthritis susceptible mice. Proc Am Soc Exp Biol 43:1991, 1984
100. Peterson LD, Thies F, Calder PC: Dose-dependent effects of dietary gamma-linolenic acid on rat spleen lymphocyte functions. Prostaglandins Leukot Essent Fatty Acids 61:19-24, 1999
101. Belch JJ, Hill A: Evening primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr 71:352S-356S, 2000 (suppl 1)
102. Hall AV, Parbtani A, Clark WF, et al: Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. Am J Kidney Dis 22:326-332, 1993
103. Clark WF, Parbtani A, Huff MW, et al: Flaxseed: A potential treatment for lupus nephritis. Kidney Int 48:475-480, 1995
104. Parbtani A, Clark WF: Flaxseed and its components in renal disease, in Cunnane S, Thompson LU (eds): Flaxseed in Human Nutrition. Champaign, IL, American Oil Chemists Society Press, 1995, pp 262-278
105. Alonso L, Marcos ML, Blanco JG, et al: Anaphylaxis caused by linseed (flaxseed) intake. J Allergy Clin Immunol 98:469-470, 1996
106. Tao X, Lipsky PE: The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am 26:29-50, 2000
107. Tao X, Sun Y, Zhang N: Treatment of rheumatoid arthritis with low doses of Tripterygium wilfordii. Chin J Integrated Tradit West Med 10:289-291, 1990
108. Kao NL, Richmond GW, Moy JN: Resolution of severe lupus nephritis associated with Tripterygium wilfordii hook F ingestion. Arthritis Rheum 36:1751-1752, 1993
109. Ye RG, Ren GH, Li HQ: Therapy of integrated traditional Chinese medicine and Western medicine on 74 lupus nephritis. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 14:343-345, 324, 1994
110. Ho LJ, Chang DM, Chang ML, et al: Mechanism of immunosuppression of the antiirheumatic herb TWHf in human T cells. J Rheumatol 26:14-24, 1999
111. Ramgolam V, Ang SG, Lai YH, et al: Traditional Chinese medicines as immunosuppressive agents. Ann Acad Med Singapore 29:11-16, 2000
112. Chou WC, Wu CC, Yang PC, et al: Hypovolemic shock and mortality after ingestion of Tripterygium wilfordii hook F.: A case report. Int J Cardiol 49:173-177, 1995
113. Takei A, Nagashima G, Suzuki R, et al: Meningoencephalocele associated with Tripterygium wilfordii treatment. Pediatr Neurosurg 27:45-48, 1997
114. YangBC, Liu CW, Chen YC, et al: Exogenous dehydroepiandrosterone modified the expression of T helper-related cytokines in NZB/NZW F1 mice. Immunol Invest 27:291-302, 1998
115. MatsunagaA, Miller BC, Cottam GL: Dehydroisoandrosterone prevention of autoimmune disease in NZB/W F1 mice: Lack of an effect on associated immunological abnormalities. Biochim Biophys Acta 992:265-271, 1989
116. Miller BC, Lau HW, Tyler NE, et al: Liver composition and lipid metabolism in NZB/W F1 female mice fed dehydroisoandrosterone. Biochim Biophys Acta 962:25-36, 1989
117. Van Vollenhoven RF, Engleman EG, McGuire JL: Dehydroisoandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheum 38:1826-1831, 1995
118. Van Vollenhoven RF, Park JL, Genovese MC, et al: A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 8:181-187, 1999
119. Van Vollenhoven RF, Morabito LM, Engleman EG, et al: Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol 25:285-289, 1998
120. Barry NN, McGuire JL, Van Vollenhoven RF: Dehydroepiandrosterone in systemic lupus erythmatosus: Relationship between dosage, serum levels, and clinical response. J Rheumatol 25:2352-2356, 1998
121. Suzuki T, Suzuki N, Engleman EG, et al: Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol 99:251-255, 1995
122. Steinberg AD, Melez KA, Raveche ES, et al: Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 22:1170-1176, 1979
123. Van Vollenhoven RF, McGuire JL: Estrogen, progesterone, and testosterone: Can they be used to treat autoimmune disease? Cleve Clin J Med 61:276-284, 1994
124. Lahita RG: The connective tissue diseases and the overall influence of gender. Int J Fertil Menopausal Stud 41:156-165, 1996
125. Suzuki T, Suzuki N, Sakane T: Hormones and lupus: Defective dehydroepiandrosterone activity induces impaired interleukin- 2 activity of T lymphocytes in patients with systemic lupus erythematosus. Ann Med Interne (Paris) 147:248-252, 1996
126. Morales AJ, Nolan JJ, Nelson JC, et al: Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367, 1994
127. Casson PR, Carson SA: Androgen replacement therapy in women: Myths and realities. Int J Fertil Menopausal Stud 41:412-422, 1996
128. Schwartz AG, Lewbart ML, Pashko LL: Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats. Cancer Res 48:4817-4822, 1988
129. Rao MS, Subbarao V, Yeldandi AV, et al: Hepatocarcinogenity of dehydroepiandrosterone in the rat. Cancer R es 52:2977-2979, 1992
130. Carr RI, Wold RT, Farr RS: Antibodies to bovine gamma globulin (BCG): And the occurrence of a BCG-like substance in systemic lupus erythematosus sera. J Allergy Clin Immunol 50:18-30, 1972
131. Diumenjo MS, Lisanti M, Valles R, et al: Allergic manifestations of systemic lupus erythematosus. Allergol Immunopathol (Madr) 13:323-326, 1985
132. Cooke HM, Reading CM: Dietary intervention in systemic lupus erythematosus: 4 cases of clinical remission and reversal of abnormal pathology. Int Clin Nutr Rev 5:166-176, 1985
133. Rea WJ, Brown OD: Mechanisms of environmental vascular triggering. Clin Ecology 3:122-128, 1985
134. Sambrook PN: Corticosteroid induced osteoporosis. J Rheumatol Suppl 45:19-22, 1996
135. Berchtold P, Seitz M: Immunosuppression - A tightrope walk between iatrogenic harm and therapy. Schweiz Med Wochenschr 126:1603-1609, 1996
136. Skolnick AA: R heumatologist issue guidelines for preventing and treating corticosteroid- induced osteoporosis. JAMA 277:98-99, 1997
137. Gilboe IM, Kvien TK, Haugeberg G, et al: Bone mineral density in systemic lupus erythematosus: Comparison with rheumatoid arthritis and healthy controls. Ann Rheum Dis 59:110-115, 2000
138. Kipen Y, Buchbinder R, Forbes A, et al: Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 24:1922-1929, 1997
139. Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 50:137-195, 1932
140. Peat ID, Healy S, Reid DM, et al: Steroid induced osteoporosis: An opportunity for prevention. Ann Rheum Dis 54:66-68, 1995
141. Miller ML, Magilavy DB, Warren RW: The immunologic basis of lupus. Pediatr Clin North Am 33:1191-1202, 1986
142. Danieli MG, Candela M: Diet and autoimmunity. Recenti Prog Med 81:532-538, 1990